Editorial governance
Dr. Parmis Mojarab
Dr. Parmis Mojarab serves as Editorial Auditor for Tirzepatide Editorial. This is an editorial-governance function: reviewing published pages for adherence to editorial standards, evidence policy, and disclosure requirements. It is distinct from medical review, which is performed by our named medical reviewer and lead clinical reviewer. No clinical-review authority or medical credential is asserted for this role.
Key takeaways
- Dr. Parmis Mojarab is Editorial Auditor, affiliated with Semaglutide Watchdog.
- This profile publishes only confirmed role information.
- Credential, license, institution, and specialty details are not published here pending independent verification.
- Editorial governance is distinct from medical review and asserts no medical credential.
| Role | Editorial Auditor |
|---|---|
| Affiliation | Semaglutide Watchdog |
| Review scope | Editorial-governance review of published pages for adherence to editorial standards, evidence policy, and disclosure requirements. Not medical review. |
| Credential / license | Not published here pending independent verification. No clinical-review authority or medical credential is asserted. |
| Function | Editorial governance — distinct from medical review |
Role
Dr. Parmis Mojarab serves as Editorial Auditor. This profile lists only confirmed role information. Additional credential, license, institution, and specialty details are not published here pending independent verification, and no clinical-review authority or medical credential is asserted for this role. The Editorial Auditor reviews published pages for adherence to our editorial standards, evidence policy, and disclosure requirements. This is an editorial-governance function and is distinct from medical review.
How much of this site's data is actually verified?
| Group | Records |
|---|---|
| Trials with full identifiers | 8 |
| Trials partially verified | 1 |
| Trials withheld pending audit | 1 |
| Providers with verified all-in price | 5 |
| Providers excluded with reason | 19 |
| Evidence status | Definition | What may be published |
|---|---|---|
| Verified | Checked against a primary source with a recorded date | The claim, with its identifier and date |
| Partially verified | Some elements confirmed, others outstanding | Confirmed elements only; the rest labelled |
| Verification Pending | Not yet checked against a primary source | No factual assertion — the gap is shown |
What are the limits of what this page can tell you?
Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.
- The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
- Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
- Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
- Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.
What would change the conclusion on this page?
Any of the following would change what this page concludes:
- New primary evidence bearing directly on dr. parmis mojarab.
- A change to FDA labelling affecting any statement made above.
- A verified correction submitted through the corrections process and accepted on the evidence.
- A material change to a captured record, including a price, term, or regulatory status.
- Completion of a verification currently marked pending, which would replace a gap with a stated fact.
Change history
| Date | Change |
|---|---|
| 2026-07-22 | Page published with current dataset snapshot. |
Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.